Clinical Trials Using Fluorine F 18 FP-R01-MG-F2

Clinical trials are research studies that involve people. The clinical trials on this list are studying Fluorine F 18 FP-R01-MG-F2. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET / CT in Measuring Response in Patients with Pancreatic Cancer and Healthy Volunteers

    This pilot clinical trial studies the use of integrin alpha-v-beta [18F]-R01-MG-F2 positron emission tomography (PET) / computed tomography (CT) in measuring response in patients with pancreatic cancer and healthy volunteers. Integrins, such as integrin alpha-v-beta [18F]-R01-MG-F2, are a family of membrane receptors that are overexpressed and attaches to various proteins which sense and respond to contact events that occur at the cell surface and may improve early detection of pancreatic cancer and improve patient selection for anti-integrin alpha-v-beta 6 therapy.
    Location: Stanford Cancer Institute Palo Alto, Palo Alto, California